HELP · NASDAQ
Helus Pharma (HELP) Stock Price & Fundamentals
$524.01−0.64%−$3.35End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Helus Pharma (HELP) closed at $524.01 on Oct 9, 2026, down 0.64% from the previous close of $527.36.
Share price, past year
1Y +1.37%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $524.01 |
| Sep 30, 2026 | $527.32 |
| Aug 31, 2026 | $504.54 |
| Jul 31, 2026 | $509.88 |
| Jun 30, 2026 | $531.34 |
| May 29, 2026 | $564.20 |
| Apr 30, 2026 | $556.65 |
| Mar 31, 2026 | $536.70 |
| Feb 27, 2026 | $517.43 |
| Jan 30, 2026 | $512.90 |
| Dec 31, 2025 | $526.43 |
| Nov 28, 2025 | $522.34 |
| Oct 31, 2025 | $513.60 |
Key statistics
- 52-week range
- $496.08 – $572.98
Financials
Helus Pharma reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Helus Pharma Inc.
- Ticker
- HELP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 100 King Street West, Suite 5600, Toronto
- Incorporated in
- A1
- Fiscal year ends
- March
- SEC CIK
- 0001833141
Frequently asked questions
What is Helus Pharma's stock price?
Helus Pharma (HELP) closed at $524.01 on Oct 9, 2026, down 0.64% from the previous close of $527.36.
Sources and methodology
Fundamentals come from Helus Pharma Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures